Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Katherine Bull

NDM Collaborators


Katherine Bull

Clinician Scientist

Oxford Kidney Pathology Group

Dr Katherine Bull is a group leader in the Centre for Human Genetics and Honorary Consultant Nephrologist in the Oxford Kidney Unit. She previously held an MRC-Kidney Research UK Professor David Kerr Clinician Scientist fellowship. 

Outline of Research

The development of new therapies for kidney disease is hampered by limited understanding of the underlying mechanistic pathways at the cellular level. This contrasts with the situation in cancer biology for example, where detailed understanding of cell biology, including the immune response, is transforming treatment. To make such advances for patients with renal disease, our objective has been to develop a variety of clinical models and tools, and then establish new approaches to interrogate tissue cellular pathology. We apply gene editing, single cell transcriptomics, and renal and immune phenotyping, to models and human samples. 

In particular our work focuses on glomerular protein leak, a hallmark of many renal pathologies. 

Examples of our work

The effects of Immune complex deposition on glomerular renal cells in lupus nephritis

Autoimmune renal disease such as occurs in Systemic Lupus Erythematosus (SLE) is characterised by the deposition of immune complexes in the renal glomeruli, but little is understood about the cellular responses in the tissue that ultimately lead to renal failure for some patients with SLE. Using inducible models and spatial transcriptomics we are interrogating cellular signals and cross talk in the kidney. 

The role of Prolidase in autoimmunity and T cell fate

Deficiency in the metalloproteinase prolidase results in a very rare condition with recurrent infections and in some cases autoimmune features including renal immune complex disease. In vivo knock out of the PEPD gene has identified key functions for prolidase in autoimmunity, renal disease and T cell differentiation. 


Richard Cornall, University of Oxford

John Todd / Diabetes and Inflammation Laboratory, University of Oxford 

Moin Saleem, University of Bristol 

Rutger Ploeg / Oxford Transplant Biobank, University of Oxford 

geneTIGA consortium

Recent publications

More publications